Abstract
Pulmonary epithelioid hemangioendothelioma (PEH), previously known as "intravascular bronchoalveolar tumor," is a rare vascular malignancy with an unpredictable prognosis. Treatment can vary from observation in asymptomatic patients to surgery in patients with resectable disease or chemotherapy in patients with disseminated disease. This report describes the clinical, radiological and pathological features of three cases of PEH and a review of the current literature.
| Original language | English |
|---|---|
| Pages (from-to) | 676-679 |
| Number of pages | 4 |
| Journal | Israel Medical Association Journal |
| Volume | 13 |
| Issue number | 11 |
| State | Published - Nov 2011 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Intravascular bronchoalveolar tumor
- Lung cancer
- Pulmonary epithelioid hemangioendothelioma (PEH)
- Transbronchial biopsy
Fingerprint
Dive into the research topics of 'Pulmonary epithelioid hemangioendothelioma'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver